30-day outcome | P (Chi-square analysis) | |||||
---|---|---|---|---|---|---|
Survived | Deceased | |||||
Count | % | Count | % | |||
Age (years) | Lowk | 53 | 54 | 3 | 25 | 0.057 |
(median) | Highl | 45 | 46 | 9 | 75 | |
Creatinine (µmol/l) (median) | Low | 56 | 57 | 3 | 25 | < 0.05 |
High | 42 | 43 | 9 | 75 | ||
eGFRa (ml/min/1.73m2) median | Low | 47 | 48 | 9 | 75 | 0.077 |
High | 51 | 52 | 3 | 25 | ||
WBCb count (x10i/l) (median) | Low | 53 | 54 | 1 | 8 | < 0.01 |
High | 45 | 46 | 11 | 92 | ||
Neutrophil count (x10i/l) (median) | Low | 48 | 49 | 1 | 8 | < 0.01 |
High | 50 | 51 | 11 | 92 | ||
Lymphocyte count (x10i/l) (median) | Low | 42 | 43 | 9 | 75 | < 0.05 |
High | 56 | 57 | 3 | 25 | ||
NLRc (median) | Low | 48 | 49 | 0 | 0 | = 0.001 |
High | 50 | 51 | 12 | 100 | ||
CRPd (mg/l) (median) | Low | 53 | 54 | 1 | 8 | < 0.01 |
High | 45 | 46 | 11 | 92 | ||
B cell modulation | ||||||
BAFFe (pg/ml) (median) | Low | 53 | 54 | 2 | 17 | < 0.05 |
High | 45 | 46 | 10 | 83 | ||
IL-4f (pg/ml) (median) | Low | 51 | 52 | 4 | 33 | NS |
High | 47 | 48 | 8 | 67 | ||
IFN-αg (pg/ml) (median) | Low | 52 | 53 | 2 | 17 | < 0.05 |
High | 46 | 47 | 10 | 83 | ||
T cell modulation | ||||||
sCD25h/IL-2Rαi (pg/ml) (median) | Low | 53 | 54 | 2 | 17 | < 0.05 |
High | 45 | 46 | 10 | 83 | ||
sCD40L (pg/ml) (median) | Low | 51 | 52 | 4 | 33 | NS |
High | 47 | 48 | 8 | 67 | ||
sPD-L1j (pg/ml) (median) | Low | 52 | 53 | 3 | 25 | 0.067 |
High | 46 | 47 | 9 | 75 | ||
sCD95/Fas (pg/ml) (median) | Low | 52 | 53 | 3 | 25 | 0.067 |
High | 46 | 47 | 9 | 75 |